Global EditionASIA 中文双语Français
Home / World / Asia-Pacific

Sinopharm leads delivery of COVID vaccines via COVAX

By WANG XIAOYU | China Daily | Updated: 2021-08-13 07:41
Share - WeChat
A nurse holds a syringe containing a COVID-19 vaccine made by the Beijing Institute of Biological Products, a unit of Sinopharm subsidiary China National Biotec Group (CNBG), at a vaccination center in Beijing, April 15, 2021. [Photo/Agencies]

More than 2.6 million COVID-19 vaccine doses from Chinese company Sinopharm arrived in Pakistan and Bangladesh this week as part of international efforts to help developing countries tackle the pandemic.

A shipment of 1.7 million doses was sent from Beijing on Tuesday morning and arrived in Dhaka, capital of Bangladesh, in the evening, the company said.

More than 976,000 doses of Sinopharm's two-shot vaccine arrived in Pakistan's capital Islamabad on Wednesday morning.

Yan Hualong, minister counselor of the Chinese embassy in Bangladesh, said in an online post that an additional 1.77 million Sinopharm doses under the COVAX program were transported from Beijing on Wednesday and would arrive in Dhaka via Doha, Qatar's capital city.

Sinopharm has pledged to supply 170 million COVID-19 doses by the first half of next year to COVAX, an international initiative that distributes vaccines to low- and middle-income countries.

The United Nations Children's Fund, one of the co-leaders of the COVAX program, said on Wednesday that another 5.1 million Sinopharm doses were scheduled to arrive Bangladesh in the next four days to boost the national vaccination drive.

Yan added that China and Bangladesh will soon start coproduction of the vaccine. Building joint production facilities overseas to manufacture China-developed vaccines has become an increasingly popular approach to boosting local vaccine supplies.

Mushtaq Hussain, an adviser to Bangladesh's Institute of Epidemiology, Disease Control and Research, said during an interview with Xinhua News Agency that Chinese vaccines had come at a critical moment for his country and will greatly help the rollout of the nationwide immunization campaign.

One local vaccination chief told Xinhua that Chinese vaccines have proved effective against the Delta variant. Bangladesh is coping with a surge of new cases fueled by the highly contagious strain.

Another Chinese drugmaker, Sinovac Biotech, plans to provide 380 million doses of its COVID-19 vaccine to COVAX by June 2022. The first shipment will arrive in Algeria this month.

Most Viewed in 24 Hours
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349